Entera Bio Ltd. (ENTX) has 9 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Aug. 7, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 7, 2026 | Malca Yonatan Director | $0 | 22,815 | +29% | No | |
|
|
||||||
| Aug. 7, 2026 | Taitel Haya Director | $0 | 20,790 | +21% | No | |
|
|
||||||
| Aug. 7, 2026 | Ellis Sean Director | $0 | 60,034 | +100% | No | |
|
|
||||||
| Aug. 7, 2026 | Yaacov-Garbeli Dana Chief Financial Officer | $0 | 140,000 | 0% | No | |
|
|
||||||
| Aug. 7, 2026 | Galitzer Hillel Chief Operating Officer | $0 | 200,000 | 0% | No | |
|
|
||||||
Showing the 5 most recent of 9 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free